New Square Capital LLC Gsk PLC Transaction History

New Square Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$42.05 - $47.77 $5,634 - $6,401	-134 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$34.27 - $40.01 $3,427 - $4,001	-100 Reduced 42.74%	134 $5,000
Q3 2020 Nov 04, 2020	SELL	$38.11 - $42.99 $5,144 - $5,803	-135 Reduced 36.59%	234 $9,000
Q2 2020 Aug 05, 2020	BUY	$37.87 - $43.58 $5,112 - $5,883	135 Added 57.69%	369 $15,000
Q4 2018 Jan 22, 2019	SELL	$37.8 - $42.69 $17,728 - $20,021	-469 Reduced 66.71%	234 $9,000
Q4 2017 Jan 29, 2018	BUY	$35.34 - $41.9 $24,844 - $29,455	703	703 $25,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.